• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 11500A
Device Problems Perivalvular Leak (1457); Detachment of Device or Device Component (2907)
Patient Problem Dyspnea (1816)
Event Date 01/23/2023
Event Type  Injury  
Manufacturer Narrative
Image evaluation: customer report of valve dehiscence could not be confirmed through image evaluation.One color picture of the inflow and one color picture of the outflow of the explanted valve were provided.The sewing ring was cut in multiple areas around the valve.Blue sutures were visible around the valve.One of the leaflets appeared to have two cuts on the outflow aspect.Echo summary: as per echo report, the submitted echocardiographic images are remarkable for: 1.Limited submitted images confined to a short axis view of the aortic valve and aortic root without and with superimposed cfd.2.An extensive, nearly circumferential (~ 270 degrees of 360 degrees) echo-lucent space around the aortic valve bioprosthesis consistent with partial valve dehiscence and a large paravalvular abscess with rupture.3.Probably torrential paravalvular aortic regurgitation (ar) involving what is presumably a ruptured paravalvular abscess.The submitted echocardiographic images support the reported findings of partial valve dehiscence (albeit without observed rocking motion of the bioprosthesis on the limited submitted images) with paravalvular abscess and probably torrential paravalvular ar.The findings are suggestive of prosthetic valve infective endocarditis.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
Edwards received notification that this inspiris resilia valve model 11500a25 implanted in the aortic position was explanted after an implant duration of four (4) months due to severe aortic regurgitation caused by partial valve dehiscence.The subject device was implanted with three hemi-continuous sutures in prolene that broke and caused the dehiscence.The issue was observed on echo.An abscess under the left cusp was also observed.The valve was evaluated for endocarditis in the hospital laboratory and it was confirmed that there was no endocarditis.The patient presented with shortness of breath.Another inspiris resilia valve of the same size was implanted in replacement with 16 single sutures.Reportedly, during the redo procedure, a pericardial patch was sutured to repair the abscess damage.The patient was discharged.
 
Manufacturer Narrative
The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.There were no issues identified that would have impacted this event.
 
Event Description
Edwards received notification that this inspiris resilia valve model 11500a25 implanted in the aortic position was explanted after an implant duration of four (4) months due to severe aortic paravalvular leak caused by partial valve dehiscence.He subject device was implanted with three hemi-continuous sutures in prolene that broke and caused the dehiscence.The issue was observed on echo.An abscess under the left cusp was also observed.The valve was evaluated for endocarditis in the hospital laboratory and it was confirmed that there was no endocarditis.The patient presented with shortness of breath.Another inspiris resilia valve of the same size was implanted in replacement with 16 single sutures.Reportedly, during the redo procedure, a pericardial patch was sutured to repair the abscess damage.The patient was discharged.
 
Manufacturer Narrative
Device dehiscence may occur early or late.When it occurs in the early post-operative period, it is typically a result of inadequate device implantation in combination with friable myocardial tissue.Late dehiscence can occur as a result of successive dilatation of cardiac structures that result from progression of disease.Valve dehiscence is not a malfunction of the device.The most likely cause is patient factors, including an abscess formation under the left cusp of the valve.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INSPIRIS RESILIA AORTIC VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer Contact
saurav singh
1 edwards way
mle fl2 office m2013
irvine, CA 92614
9492506615
MDR Report Key16395427
MDR Text Key309869276
Report Number2015691-2023-10904
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 03/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number11500A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/23/2023
Initial Date FDA Received02/17/2023
Supplement Dates Manufacturer Received02/16/2023
03/27/2023
Supplement Dates FDA Received03/17/2023
03/28/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/07/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Life Threatening;
Patient Age52 YR
Patient SexMale
-
-